VTRS:Viatris Inc Snapshot | Charting | News | Options
$8.81 NASDAQ 10:00a ET
August 1 '25 		Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Con... PR Newswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on VTRS
    No News Available
    Lifshitz Law PLLC Announces Investigations of Quantum Computing, Inc....
    2:54p ET July 29 '25 ACCESSWIRE
    Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Share...
    9:20a ET July 18 '25 GlobeNewswire
    Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis
    6:59a ET July 18 '25 PR Newswire
    Viatris Certified as a Great Place to Work® in Canada
    6:59a ET July 15 '25 CNW Group
    Viatris Announces Positive Top-Line Results from Second Pivotal Phase...
    6:55a ET June 26 '25 PR Newswire
    VTRS SECURITIES: BFA Law Notifies Viatris Inc. Investors to Contact t...
    8:22a ET May 26 '25 Newsfile Corp
    VTRS DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourage...
    11:55p ET May 25 '25 Newsfile Corp
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Clai...
    9:28a ET May 25 '25 Newsfile Corp
    VTRS FRAUD: Suffer Losses on Viatris Inc.? You may have been Affected...
    7:42a ET May 25 '25 GlobeNewswire
    Join Class Action to Recover Losses from Viatris Inc. (VTRS) - Contac...
    10:53p ET May 24 '25 ACCESSWIRE

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.